Dr Joshua Bollan, MD | |
12605 E 16th Ave, Aurora, CO 80045-2545 | |
(720) 848-0000 | |
Not Available |
Full Name | Dr Joshua Bollan |
---|---|
Gender | Male |
Speciality | Geriatric Medicine |
Experience | 10 Years |
Location | 12605 E 16th Ave, Aurora, Colorado |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1285052084 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
University Of Colorado Hospital Authority | Aurora, CO | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
University Physicians Incorporated | 3476465667 | 2657 |
News Archive
It's a lot easier to negotiate a better price on something when you buy in volume - that's the approach the State Assembly is hoping the state will take when buying its prescription drugs.
New findings are bringing scientists closer to an effective HIV vaccine. Researchers from Seattle Biomedical Research Institute, Vanderbilt University and the Ragon Institute of MGH, MIT and Harvard report findings showing new evidence about broadly-reactive neutralizing antibodies, which block HIV infection. Details are published January 13 in the open-access journal PLoS Pathogens.
"Hitting the bottle is not the cure to the ills of the world" was the last message from the advertisements of New Zealand's Alcohol Advisory Council (ALAC). That campaign focused on graphic examples of excessive drinking leading to harm, with three realistic characters who made poor and dangerous choices.
Today, at the 11th Annual Meeting of the American Society of Breast Surgeons, Agendia, a world leader in molecular cancer diagnostics, announced that Breast Cancer Research and Treatment has published an important study demonstrating the benefit of adjuvant chemotherapy for patients with a high-risk of breast cancer recurrence according to the MammaPrint test. The ASBS meeting takes places April 28 - May 2, 2010, at the Bellagio in Las Vegas, where you can meet the Agendia team at booth # 314.
GenMark Diagnostics, Inc., a provider of automated, multiplex molecular diagnostic testing systems, announced today that their eSensor Warfarin Sensitivity Test has been selected for use in a new pivotal Warfarin clinical study the WARFARIN Trial.
› Verified 8 days ago
Entity Name | University Physicians Incorporated |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1962461889 PECOS PAC ID: 3476465667 Enrollment ID: O20031105000375 |
News Archive
It's a lot easier to negotiate a better price on something when you buy in volume - that's the approach the State Assembly is hoping the state will take when buying its prescription drugs.
New findings are bringing scientists closer to an effective HIV vaccine. Researchers from Seattle Biomedical Research Institute, Vanderbilt University and the Ragon Institute of MGH, MIT and Harvard report findings showing new evidence about broadly-reactive neutralizing antibodies, which block HIV infection. Details are published January 13 in the open-access journal PLoS Pathogens.
"Hitting the bottle is not the cure to the ills of the world" was the last message from the advertisements of New Zealand's Alcohol Advisory Council (ALAC). That campaign focused on graphic examples of excessive drinking leading to harm, with three realistic characters who made poor and dangerous choices.
Today, at the 11th Annual Meeting of the American Society of Breast Surgeons, Agendia, a world leader in molecular cancer diagnostics, announced that Breast Cancer Research and Treatment has published an important study demonstrating the benefit of adjuvant chemotherapy for patients with a high-risk of breast cancer recurrence according to the MammaPrint test. The ASBS meeting takes places April 28 - May 2, 2010, at the Bellagio in Las Vegas, where you can meet the Agendia team at booth # 314.
GenMark Diagnostics, Inc., a provider of automated, multiplex molecular diagnostic testing systems, announced today that their eSensor Warfarin Sensitivity Test has been selected for use in a new pivotal Warfarin clinical study the WARFARIN Trial.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Joshua Bollan, MD Po Box 110429, Aurora, CO 80042-0429 Ph: () - | Dr Joshua Bollan, MD 12605 E 16th Ave, Aurora, CO 80045-2545 Ph: (720) 848-0000 |
News Archive
It's a lot easier to negotiate a better price on something when you buy in volume - that's the approach the State Assembly is hoping the state will take when buying its prescription drugs.
New findings are bringing scientists closer to an effective HIV vaccine. Researchers from Seattle Biomedical Research Institute, Vanderbilt University and the Ragon Institute of MGH, MIT and Harvard report findings showing new evidence about broadly-reactive neutralizing antibodies, which block HIV infection. Details are published January 13 in the open-access journal PLoS Pathogens.
"Hitting the bottle is not the cure to the ills of the world" was the last message from the advertisements of New Zealand's Alcohol Advisory Council (ALAC). That campaign focused on graphic examples of excessive drinking leading to harm, with three realistic characters who made poor and dangerous choices.
Today, at the 11th Annual Meeting of the American Society of Breast Surgeons, Agendia, a world leader in molecular cancer diagnostics, announced that Breast Cancer Research and Treatment has published an important study demonstrating the benefit of adjuvant chemotherapy for patients with a high-risk of breast cancer recurrence according to the MammaPrint test. The ASBS meeting takes places April 28 - May 2, 2010, at the Bellagio in Las Vegas, where you can meet the Agendia team at booth # 314.
GenMark Diagnostics, Inc., a provider of automated, multiplex molecular diagnostic testing systems, announced today that their eSensor Warfarin Sensitivity Test has been selected for use in a new pivotal Warfarin clinical study the WARFARIN Trial.
› Verified 8 days ago
Dr. Martin W Rausch, MD Hospitalist Medicare: Not Enrolled in Medicare Practice Location: 2550 S Parker Rd, Aurora, CO 80014 Phone: 303-338-4545 | |
Peter Boulos, M.D. Hospitalist Medicare: Medicare Enrolled Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 303-724-5524 | |
John Watson Iv, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-1234 | |
Thuy-quynh Jennifer Le, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 13001 E 17th Pl, Aurora, CO 80045 Phone: 303-724-6595 | |
Hillary L Western, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Dr. Hemali P Patel, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 12401 E 17th Ave, Suite 450b Mail Stop F-782, Aurora, CO 80045 Phone: 720-848-4289 Fax: 720-848-4293 | |
Madison Hibshman, Hospitalist Medicare: Medicare Enrolled Practice Location: 13001 E 17th Pl, Aurora, CO 80045 Phone: 303-724-1784 |